Article
A multicenter survey on BRAF screening for the implementation of perioperative cancer genomic medicine for resectable colorectal oligometastases.
International journal of clinical oncology - 1 Sept 2026
Kobayashi Shin, Matsuhashi Nobuhisa, Suwa Yusuke, Kawazoe Tetsuro, Ouchi Akira, Shiozawa Manabu, Shiomi Akio, Yokota Mitsuru, Shinozaki Eiji, Takamizawa Yasuyuki, Nishizawa Yujiro, Hiyoshi Yukiharu, Kakisaka Tatsuhiko, Ohnuma Shinobu, Ogura Toshiro, Hasegawa Hiroko, Kotaka Masahito, Hirata Keiji, Bando Hideaki, Yoshino Takayuki
Abstract excerpt
BACKGROUND: Genomic screening is an essential, but potentially time-consuming procedure, especially in neoadjuvant settings. We evaluated the preoperative screening of the BRAF V600E mutation for recruitment to a clinical trial among patients with resectable colorectal oligometastases (CRM). METHODS: In April 2022, an investigator-initiated trial was launched to investigate the efficacy and safety of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
